Sentrian names Lance Myers new chief technology officer
December 17, 2014
Remote patient monitoring specialist Sentrian has made a number of senior management appointments, including the recruitment of Lance Myers as its new chief technology officer.
Myers is said to have been involved in physiological and biometric monitoring research and development for more than 15 years and previously worked as the chief science officer of VivoSense (San Diego, CA, USA), which develops analytic software for body-worn sensor systems.
Other new hires include Avi Moghaddam as vice president of operations, Dunnie Norman as vice president of customer development and Jeff Haggard and vice president of customer success.
“We are excited to add Lance, Avi, Dunnie and Jeff to our leadership team at this time of surging interest in the use of remote patient monitoring analytics to lower costs and improve quality of care,” said Dean Sawyer, Sentrian’s chief executive. “As a true pioneer in the area of remote biometric monitoring and analytics, Lance contributed to developing the technical foundation of Sentrian’s (Aliso Viejo, CA, USA) remote patient intelligence platform.”
“His depth of experience and expertise will be a significant contribution to our customers' success,” added Sawyer. “Avi, Dunnie, and Jeff round out our senior team with several decades of combined experience managing operations, sales, services and support for large enterprise solution providers in the healthcare IT space.”
Moghaddam, the new vice president of operations, previously worked as director of delivery services for Avitech Consulting, while customer development vice president Norman formerly held sales leadership roles at Informatica (Redwood City, CA, USA) and Allscripts (Chicago, IL, USA), where he was responsible for managing relationships with various health systems.
Meanwhile, Haggard – who will serve as a vice president of customer success – previously led national account services for Allscripts.
Sentrian launched its services last month and claims that its remote patient intelligence platform can address the challenge of managing patients with chronic diseases by offering them support when they are at home and away from their care teams.